Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions

Table of Contents

May 1, 2002; Volume 46,Issue 5

Minireviews

  • Minireview
    Antiparasitic Agent Atovaquone
    Aaron L. Baggish, David R. Hill

Chemistry; Biosynthesis

  • Chemistry; Biosynthesis
    Biosynthetic Gene Cluster of Simocyclinone, a Natural Multihybrid Antibiotic
    A. Trefzer, S. Pelzer, J. Schimana, S. Stockert, C. Bihlmaier, H.-P. Fiedler, K. Welzel, A. Vente, A. Bechthold

Mechanisms of Resistance

  • Mechanisms of Resistance
    TEM-80, a Novel Inhibitor-Resistant β-Lactamase in a Clinical Isolate of Enterobacter cloacae
    Corinne Arpin, Roger Labia, Véronique Dubois, Patrick Noury, Muriel Souquet, Claudine Quentin
  • Mechanisms of Resistance
    Origin and Evolution of the AmpC β-Lactamases of Citrobacter freundii
    Miriam Barlow, Barry G. Hall
  • Mechanisms of Resistance
    Emergence of Group A Streptococcus Strains with Different Mechanisms of Macrolide Resistance
    Edouard Bingen, Roland Leclercq, Frédéric Fitoussi, Naïma Brahimi, Brigitte Malbruny, Dominique Deforche, Robert Cohen
  • Mechanisms of Resistance
    Fitness Cost of Chromosomal Drug Resistance-Conferring Mutations
    Peter Sander, Burkhard Springer, Therdsak Prammananan, Antje Sturmfels, Martin Kappler, Michel Pletschette, Erik C. Böttger
  • Mechanisms of Resistance
    ColE1-Like Plasmid pIP843 of Klebsiella pneumoniae Encoding Extended-Spectrum β-Lactamase CTX-M-17
    Van Cao, Thierry Lambert, Patrice Courvalin
  • Mechanisms of Resistance
    A Missense Mutation in the fabB (β-Ketoacyl-Acyl Carrier Protein Synthase I) Gene Confers Thiolactomycin Resistance to Escherichia coli
    Suzanne Jackowski, Yong-Mei Zhang, Allen C. Price, Stephen W. White, Charles O. Rock
  • Mechanisms of Resistance
    Identification of Essential Residues in the Erm(B) rRNA Methyltransferase of Clostridium perfringens
    Kylie A. Farrow, Dena Lyras, Galina Polekhina, Katerina Koutsis, Michael W. Parker, Julian I. Rood
  • Mechanisms of Resistance
    Characterization of Plasmids Carrying CMY-2 from Expanded-Spectrum Cephalosporin-Resistant Salmonella Strains Isolated in the United States between 1996 and 1998
    A. Carattoli, F. Tosini, W. P. Giles, M. E. Rupp, S. H. Hinrichs, F. J. Angulo, T. J. Barrett, P. D. Fey
  • Mechanisms of Resistance
    Effects of Amino Acid Alterations in Penicillin-Binding Proteins (PBPs) 1a, 2b, and 2x on PBP Affinities of Penicillin, Ampicillin, Amoxicillin, Cefditoren, Cefuroxime, Cefprozil, and Cefaclor in 18 Clinical Isolates of Penicillin-Susceptible, -Intermediate, and -Resistant Pneumococci
    Kensuke Nagai, Todd A. Davies, Michael R. Jacobs, Peter C. Appelbaum
  • Mechanisms of Resistance
    Widespread Distribution of a Tet W Determinant among Tetracycline-Resistant Isolates of the Animal Pathogen Arcanobacterium pyogenes
    Stephen J. Billington, J. Glenn Songer, B. Helen Jost
  • Mechanisms of Resistance
    Characterization and Movement of the Class 1 Integron Known as Tn2521 and Tn1405
    Sally R. Partridge, Heidi J. Brown, Ruth M. Hall
  • Mechanisms of Resistance
    Presence of a Group II Intron in a Multiresistant Serratia marcescens Strain That Harbors Three Integrons and a Novel Gene Fusion
    Daniela Centrón, Paul H. Roy
  • Mechanisms of Resistance
    tcrB, a Gene Conferring Transferable Copper Resistance in Enterococcus faecium: Occurrence, Transferability, and Linkage to Macrolide and Glycopeptide Resistance
    Henrik Hasman, Frank M. Aarestrup
  • Mechanisms of Resistance
    High Prevalence of KatG Ser315Thr Substitution among Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates from Northwestern Russia, 1996 to 2001
    Igor Mokrousov, Olga Narvskaya, Tatiana Otten, Elena Limeschenko, Lidia Steklova, Boris Vyshnevskiy
  • Mechanisms of Resistance
    Plasmidic Extended-Spectrum β-Lactamases in Vibrio cholerae O1 El Tor Isolates in Argentina
    Alejandro Petroni, Alejandra Corso, Roberto Melano, María Luisa Cacace, Ana María Bru, Alicia Rossi, Marcelo Galas
  • Mechanisms of Resistance
    Bloodstream Infections by Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Children: Epidemiology and Clinical Outcome
    Yun-Kyung Kim, Hyunjoo Pai, Hoan-Jong Lee, Su-Eun Park, Eun-Hwa Choi, Jungmin Kim, Je-Hak Kim, Eui-Chong Kim
  • Mechanisms of Resistance
    Accessory Gene Regulator (agr) Locus in Geographically Diverse Staphylococcus aureus Isolates with Reduced Susceptibility to Vancomycin
    George Sakoulas, George M. Eliopoulos, Robert C. Moellering, Christine Wennersten, Lata Venkataraman, Richard P. Novick, Howard S. Gold
  • Mechanisms of Resistance
    Antagonism between Aminoglycosides and β-Lactams in a Methicillin-Resistant Staphylococcus aureus Isolate Involves Induction of an Aminoglycoside-Modifying Enzyme
    Takashi Ida, Ryoichi Okamoto, Masato Nonoyama, Kazuhiko Irinoda, Mizuyo Kurazono, Matsuhisa Inoue
  • Mechanisms of Resistance
    Chromosomal System for Studying AmpC-Mediated β-Lactam Resistance Mutation in Escherichia coli
    Joseph F. Petrosino, Amanda R. Pendleton, Joel H. Weiner, Susan M. Rosenberg
  • Mechanisms of Resistance
    30S Ribosomal Subunit Assembly Is a Target for Inhibition by Aminoglycosides in Escherichia coli
    Roopal Mehta, W. Scott Champney
  • Mechanisms of Resistance
    New Mg2+-Dependent Oxytetracycline Resistance Determinant Tet 34 in Vibrio Isolates from Marine Fish Intestinal Contents
    Lisa Nonaka, Satoru Suzuki
  • Mechanisms of Resistance
    Association of Metronidazole Resistance and Natural Competence in Helicobacter pylori
    Yu-Ching Yeh, Kai-Chin Chang, Jyh-Chin Yang, Chi-Tai Fang, Jin-Town Wang
  • Mechanisms of Resistance
    rpoB Mutation Conferring Rifampin Resistance in Streptococcus pyogenes
    Hélène Aubry-Damon, Marc Galimand, Guy Gerbaud, Patrice Courvalin
  • Mechanisms of Resistance
    Macrolide and Tetracycline Resistance and Molecular Relationships of Clinical Strains of Streptococcus agalactiae
    Esther Culebras, Iciar Rodriguez-Avial, Carmen Betriu, Montserrat Redondo, Juan J. Picazo
  • Mechanisms of Resistance
    Outbreak of Infections Caused by Enterobacter cloacae Producing the Integron-Associated β-Lactamase IBC-1 in a Neonatal Intensive Care Unit of a Greek Hospital
    Georgia Kartali, Eva Tzelepi, Spyros Pournaras, Constantina Kontopoulou, Fanourios Kontos, Danai Sofianou, Antonios N. Maniatis, Athanassios Tsakris
  • Mechanisms of Resistance
    Site-Specific Recombination with the Chromosomal tRNALeu Gene by the Large Conjugative Haemophilus Resistance Plasmid
    Ioanna D. Dimopoulou, Joanne E. Russell, Zaini Mohd-Zain, Rebecca Herbert, Derrick W. Crook
  • Mechanisms of Resistance
    Characterization of a Laboratory-Derived, High-Level Ampicillin-Resistant Salmonella enterica Serovar Typhimurium Strain That Caused Meningitis in an Infant
    Cheng-Hsun Chiu, Chishih Chu, Lin-Hui Su, Wan-Yu Wu, Tsu-Lan Wu

Susceptibility

  • Susceptibility
    Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to Membrane-Active Peptides and Enrofloxacin in Human Tissue Cell Cultures
    Ran Nir-Paz, Marie-Christine Prévost, Pierre Nicolas, Alain Blanchard, Henri Wróblewski
  • Susceptibility
    Antibacterial Activity of Licochalcone A against Spore-Forming Bacteria
    Ryo-Ichi Tsukiyama, Harumi Katsura, Nozomu Tokuriki, Makio Kobayashi
  • Susceptibility
    NB2001, a Novel Antibacterial Agent with Broad-Spectrum Activity and Enhanced Potency against β-Lactamase-Producing Strains
    Qing Li, Jean Y. Lee, Rosario Castillo, Mark S. Hixon, Catherine Pujol, Venkata Ramana Doppalapudi, H. Michael Shepard, Geoffrey M. Wahl, Thomas J. Lobl, Ming Fai Chan
  • Susceptibility
    Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in Canada during 2000
    Donald E. Low, Joyce de Azavedo, Karl Weiss, Tony Mazzulli, Magdalena Kuhn, Deirdre Church, Kevin Forward, George Zhanel, Andrew Simor, A. McGeer
    and Canadian Bacterial Surveillance Network
  • Susceptibility
    Effects of Compounds Found in Propolis on Streptococcus mutans Growth and on Glucosyltransferase Activity
    Hyun Koo, Pedro L. Rosalen, Jaime A. Cury, Yong K. Park, William H. Bowen
  • Susceptibility
    Purification, Characterization, and Identification of Novel Inhibitors of the β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) from Staphylococcus aureus
    Xin He, Kevin A. Reynolds
  • Susceptibility
    Antimicrobial Activity of Quinupristin-Dalfopristin Combined with Other Antibiotics against Vancomycin-Resistant Enterococci
    G. M. Eliopoulos, C. B. Wennersten
  • Susceptibility
    A Chemically Modified Tetracycline (CMT-3) Is a New Antifungal Agent
    Yu Liu, Maria E. Ryan, Hsi-Ming Lee, Sanford Simon, George Tortora, Carol Lauzon, Michael K. Leung, Lorne M. Golub
  • Susceptibility
    Potato Dextrose Agar Antifungal Susceptibility Testing for Yeasts and Molds: Evaluation of Phosphate Effect on Antifungal Activity of CMT-3
    Yu Liu, George Tortora, Maria E. Ryan, Hsi-Ming Lee, Lorne M. Golub
  • Susceptibility
    In Vitro Interactions of Artemisinin with Atovaquone, Quinine, and Mefloquine against Plasmodium falciparum
    S. Gupta, M. M. Thapar, W. H. Wernsdorfer, A. Björkman
  • Susceptibility
    Activities of New Fluoroquinolones, Ketolides, and Other Antimicrobials against Blood Culture Isolates of Viridans Group Streptococci from across Canada, 2000
    Andrea S. Gershon, Joyce C. S. de Azavedo, Allison McGeer, Krystyna I. Ostrowska, Deirdre Church, Daryl J. Hoban, Godfrey K. M. Harding, Karl Weiss, Lewis Abbott, Fiona Smaill, Marie Gourdeau, Gilles Murray, Donald E. Low
    and Canadian Bacterial Surveillance Network
  • Susceptibility
    In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of Zygomycetes
    Qiu N. Sun, Annette W. Fothergill, Dora I. McCarthy, Michael G. Rinaldi, John R. Graybill
  • Susceptibility
    In Vitro Activities of Free and Lipid Formulations of Amphotericin B and Nystatin against Clinical Isolates of Coccidioides immitis at Various Saprobic Stages
    Gloria M. González, Rolando Tijerina, Deanna A. Sutton, John R. Graybill, Michael G. Rinaldi
  • Susceptibility
    In Vitro Activity of Linezolid against Clostridium difficile
    T. Peláez, R. Alonso, C. Pérez, L. Alcalá, O. Cuevas, E. Bouza

Antiviral Agents

  • Antiviral Agents
    Characterization of Imidazo[4,5-d]Pyridazine Nucleosides as Modulators of Unwinding Reaction Mediated by West Nile Virus Nucleoside Triphosphatase/Helicase: Evidence for Activity on the Level of Substrate and/or Enzyme
    Peter Borowski, Melanie Lang, Annemarie Haag, Herbert Schmitz, Joonho Choe, Huan-Ming Chen, Ramachandra S. Hosmane
  • Antiviral Agents
    Characterization of Wild-Type and Cidofovir-Resistant Strains of Camelpox, Cowpox, Monkeypox, and Vaccinia Viruses
    Donald F. Smee, Robert W. Sidwell, Debbie Kefauver, Mike Bray, John W. Huggins
  • Antiviral Agents
    Anti-Human Immunodeficiency Virus Interactions of SCH-C (SCH 351125), a CCR5 Antagonist, with Other Antiretroviral Agents In Vitro
    Cécile L. Tremblay, Françoise Giguel, Christopher Kollmann, Yongbiao Guan, Ting-Chao Chou, Bahige M. Baroudy, Martin S. Hirsch
  • Antiviral Agents
    DPC 817: a Cytidine Nucleoside Analog with Activity against Zidovudine- and Lamivudine-Resistant Viral Variants
    Raymond F. Schinazi, John Mellors, Holly Bazmi, Sharon Diamond, Sena Garber, Karen Gallagher, Romas Geleziunas, Ron Klabe, Michael Pierce, Marlene Rayner, Jing-Tao Wu, Hangchun Zhang, Jennifer Hammond, Lee Bacheler, Douglas J. Manion, Michael J. Otto, Lieven Stuyver, George Trainor, Dennis C. Liotta, Susan Erickson-Viitanen
  • Antiviral Agents
    Effects of Specific Zidovudine Resistance Mutations and Substrate Structure on Nucleotide-Dependent Primer Unblocking by Human Immunodeficiency Virus Type 1 Reverse Transcriptase
    Peter R. Meyer, Suzanne E. Matsuura, Adviye A. Tolun, Ingrid Pfeifer, Antero G. So, John W. Mellors, Walter A. Scott
  • Antiviral Agents
    Human Immunodeficiency Virus (HIV) Type 1 Reverse Transcriptase Resistance Mutations in Hepatitis B Virus (HBV)-HIV-Coinfected Patients Treated for HBV Chronic Infection Once Daily with 10 Milligrams of Adefovir Dipivoxil Combined with Lamivudine
    Constance Delaugerre, Anne-Geneviève Marcelin, Vincent Thibault, Gilles Peytavin, Tony Bombled, Marie-Valérie Bochet, Christine Katlama, Yves Benhamou, Vincent Calvez
  • Antiviral Agents
    Single-Dose Pharmacokinetics of Amprenavir Coadministered with Grapefruit Juice
    D. Demarles, C. Gillotin, S. Bonaventure-Paci, I. Vincent, S. Fosse, A. M. Taburet
  • Antiviral Agents
    Tenofovir Diphosphate Is a Poor Substrate and a Weak Inhibitor of Rat DNA Polymerases α, δ, and ε*
    Gabriel Birkuš, Miroslav Hájek, Pavel Kramata, Ivan Votruba, Antonín Holý, Berta Otová

Experimental Therapeutics

  • Experimental Therapeutics
    Efficacies of Fluconazole, Caspofungin, and Amphotericin B in Candida glabrata-Infected p47phox−/− Knockout Mice
    Justina Y. Ju, Cynthia Polhamus, Kieren A. Marr, Steven M. Holland, John E. Bennett
  • Experimental Therapeutics
    Effects of Specific Antibodies against Streptococcus pneumoniae on Pharmacodynamic Parameters of β-Lactams in a Mouse Sepsis Model
    J. Casal, L. Aguilar, I. Jado, J. Yuste, M. J. Giménez, J. Prieto, A. Fenoll
  • Experimental Therapeutics
    Pharmacodynamic Activity and Efficacy of Linezolid in a Rat Model of Pneumococcal Pneumonia
    Martha J. Gentry-Nielsen, Keith M. Olsen, Laurel C. Preheim
  • Experimental Therapeutics
    In Vitro and In Vivo Activities of Posaconazole against Coccidioides immitis
    Gloria M. González, Rolando Tijerina, Laura K. Najvar, Rosie Bocanegra, Michael Rinaldi, David Loebenberg, John R. Graybill
  • Experimental Therapeutics
    In Vitro and In Vivo Antifungal Activities of TAK-456, a Novel Oral Triazole with a Broad Antifungal Spectrum
    Noboru Tsuchimori, Ryogo Hayashi, Naomi Kitamoto, Kentaro Asai, Tomoyuki Kitazaki, Yuji Iizawa, Katsumi Itoh, Kenji Okonogi
  • Experimental Therapeutics
    Pharmacodynamic Assessment of Clarithromycin in a Murine Model of Pneumococcal Pneumonia
    Pamela R. Tessier, Myo-Kyoung Kim, Wen Zhou, Dawei Xuan, Chonghua Li, Min Ye, Charles H. Nightingale, David P. Nicolau
  • Experimental Therapeutics
    Effects of Metronidazole, Tetracycline, and Bismuth-Metronidazole-Tetracycline Triple Therapy in the Helicobacter pylori SS1 Mouse Model after 1 Day of Dosing: Development of an H. pylori Lead Selection Model
    Christine F. Sizemore, Joel D. Quispe, Karen M. Amsler, Todd C. Modzelewski, Jayson J. Merrill, D. Andrew Stevenson, Lorie A. Foster, Andrew M. Slee
  • Experimental Therapeutics
    Comparison of Levofloxacin, Alatrofloxacin, and Vancomycin for Prophylaxis and Treatment of Experimental Foreign-Body-Associated Infection by Methicillin-Resistant Staphylococcus aureus
    Pierre Vaudaux, Patrice Francois, Carmelo Bisognano, Jacques Schrenzel, Daniel P. Lew
  • Experimental Therapeutics
    Comparative Pharmacodynamics of Three Newer Fluoroquinolones versus Six Strains of Staphylococci in an In Vitro Model under Aerobic and Anaerobic Conditions
    David H. Wright, Brent W. Gunderson, Laurie B. Hovde, Gigi H. Ross, Khalid H. Ibrahim, John C. Rotschafer
  • Experimental Therapeutics
    Different Aminoglycoside-Resistant Phenotypes in a Rabbit Staphylococcus aureus Endocarditis Infection Model
    N. Asseray, J. Caillon, N. Roux, C. Jacqueline, R. Bismuth, M. F. Kergueris, G. Potel, D. Bugnon
  • Experimental Therapeutics
    Design and Antileishmanial Activity of Amphotericin B-Loaded Stable Ionic Amphiphile Biovector Formulations
    P. M. Loiseau, L. Imbertie, C. Bories, D. Betbeder, I. De Miguel
  • Experimental Therapeutics
    Gemifloxacin Is Efficacious against Penicillin-Resistant and Quinolone-Resistant Pneumococci in Experimental Meningitis
    Philippe Cottagnoud, Fernando Acosta, Marianne Cottagnoud, Martin G. Täuber

Analytical Procedures

  • Analytical Procedures
    Change in Colony Morphology of Candida lusitaniae in Association with Development of Amphotericin B Resistance
    Nancy B. McClenny, Haihua Fei, Ellen J. Baron, Ana C. Gales, Allison Houston, Richard J. Hollis, Michael A. Pfaller
  • Analytical Procedures
    In Vitro Plasmodium falciparum Drug Sensitivity Assay: Inhibition of Parasite Growth by Incorporation of Stomatocytogenic Amphiphiles into the Erythrocyte Membrane
    Hanne L. Ziegler, Dan Stærk, Jette Christensen, Lars Hviid, Henry Hägerstrand, Jerzy W. Jaroszewski

Pharmacology

  • Pharmacology
    Pharmacokinetics of Amino Acid Phosphoramidate Monoesters of Zidovudine in Rats
    Heng Song, George W. Griesgraber, Carston R. Wagner, Cheryl L. Zimmerman
  • Pharmacology
    Effect of Telithromycin (HMR 3647) on Polymorphonuclear Neutrophil Killing of Staphylococcus aureus in Comparison with Roxithromycin
    D. Vazifeh, H. Abdelghaffar, M. T. Labro
  • Pharmacology
    PEPT1-Mediated Cefixime Uptake into Human Intestinal Epithelial Cells Is Increased by Ca2+ Channel Blockers
    Uwe Wenzel, Sabine Kuntz, Simone Diestel, Hannelore Daniel
  • Pharmacology
    Nonparametric Population Pharmacokinetic Analysis of Amikacin in Neonates, Infants, and Children
    J. M. Tréluyer, Y. Merlé, S. Tonnelier, E. Rey, G. Pons
  • Pharmacology
    Intrapulmonary Pharmacokinetics of Linezolid
    John E. Conte, Jeffrey A. Golden, Juliana Kipps, Elisabeth Zurlinden
  • Pharmacology
    Shiga-Like Toxin II Derived from Escherichia coli O157:H7 Modifies Renal Handling of Levofloxacin in Rats
    Ying Lan Zhao, Xiao Bo Cen, Masafumi Ito, Keiko Yokoyama, Kenji Takagi, Kiyoyuki Kitaichi, Masayuki Nadai, Michio Ohta, Kenzo Takagi, Takaaki Hasegawa
  • Pharmacology
    Pharmacokinetics of Piperacillin-Tazobactam in Anuric Intensive Care Patients during Continuous Venovenous Hemodialysis
    Silke C. Mueller, Jolanta Majcher-Peszynska, Heiko Hickstein, Astrid Francke, Annette Pertschy, Martin Schulz, Ralf Mundkowski, Bernd Drewelow
  • Pharmacology
    Distribution of Azithromycin in Plasma and Tonsil Tissue after Repeated Oral Administration of 10 or 20 Milligrams per Kilogram in Pediatric Patients
    Corrado Blandizzi, Tecla Malizia, Giovanna Batoni, Emilia Ghelardi, Fabio Baschiera, Paolo Bruschini, Sonia Senesi, Mario Campa, Mario Del Tacca
  • Pharmacology
    Interaction between Grapefruit Juice and Praziquantel in Humans
    Nelly Castro, Helgi Jung, Roberto Medina, Dinora González-Esquivel, Mario Lopez, Julio Sotelo

Mechanisms of Action

  • Mechanisms of Action: Physiological Effects
    Interactions between Biocide Cationic Agents and Bacterial Biofilms
    C. Campanac, L. Pineau, A. Payard, G. Baziard-Mouysset, C. Roques
  • Mechanisms of Action: Physiological Effects
    Crystal Structure of (−)-Mefloquine Hydrochloride Reveals Consistency of Configuration with Biological Activity
    Jean M. Karle, Isabella L. Karle
  • MECHANISMS OF ACTION: PHYSIOLOGY EFFECTS
    Lack of Interaction of Fluoroquinolones with Lipopolysaccharides
    B. Lindner, A. Wiese, K. Brandenburg, U. Seydel, A. Dalhoff
PreviousNext
Back to top

Antimicrobial Agents and Chemotherapy: 46 (5)

In This Issue

volume 46, issue 5
  • Masthead (PDF)
Sign up for alerts

Jump to

  • Minireviews
  • Chemistry; Biosynthesis
  • Mechanisms of Resistance
  • Susceptibility
  • Antiviral Agents
  • Experimental Therapeutics
  • Analytical Procedures
  • Pharmacology
  • Mechanisms of Action
  • Most Read
  • Most Cited
Loading
  • Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2
  • Mechanism-of-Action Classification of Antibiotics by Global Transcriptome Profiling
  • Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions
  • Povidone Iodine: Properties, Mechanisms of Action, and Role in Infection Control and Staphylococcus aureus Decolonization
More...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596